is retatrutide on the market yet Retatrutide, a new weight loss drug not available yet, showing promising results in trials. @DrLaPook explains it’s doing much more than what current medications can Retatrutide, a new weight loss

The cardioprotective mechanisms of GLP-1 RAs are thought to involve a combination of anti-inflammatory and antioxidant actions, reduced secretion of atherogenic lipoproteins, improved vascular endothelial function, and blood pressure regulation 32,33

Eat nutritiously

Changing concentrations mid-study introduces variables that complicate data analysis

See also: GLP-1 Guides | Provider Comparisons BPC-157 doses in research typically range from 200 to 800 mcg per day, given once or twice daily by subcutaneous injection or oral capsule

A skin analysis helps determine if pigmentation, dullness, or oxidative stress makes you a suitable candidate

doi: 10.1021/jacsau.2c00130 de Bray A, Roberts AG, Armour S, Tong J, Huhn C, Gatin-Fraudet B, Romann K, Shilleh AH, Jiang W, Figueredo Burgos NS, Trott JPP, Viloria K, Nasteska D, Pearce A, Miyazaki S, Tomlinson JW, Owen DM, Nieves DJ, Ast J, Cyranka M, Epanchintsev A, mml C, Reimann F, Soykan T, Ladds G, Adriaenssens AE, Trapp S, Jones B, Broichhagen J, Hodson DJ